Abstract:Our previous study found that triple-negative breast cancer line MDA-MB-231 showed a higher expression of hypoxia-inducible factor 1α (HIF-1α) under nomoxic condition and a higher capability of cell growth and invasive/migratory than other breast cancer cell lines. SiRNA targed HIF-1α interrupted HIF-1α expression and suppressed the ability of cell growth and invasion/migration with a downregulation of MMP8/17/10/13 mRNA in MDA-MB-231 cell. Ubiquitin carboxyl-terminal hydrolases L3 (UCH-L3) is a kind of deubiquitinating enzyme which may hydrolyze the ubiquitinated proteins from polyubinquited compounds before degradation by proteolytic ezyme system and release ubiquitin for recycle. HIF-1α is a regulatory subunit by oxygen and degraded by ubiquitin-proteasome pathway. This study was aimed to probe the role of UCH-L3 in modulation of HIF-1α expression and its effect on malignant behavior as well as the mechanism involved.Methods: siRNA was used to interfere HIF-1α or UCH-L3 expression. Bidirectional gel electrophoresis and mass spectormetry were used to explore differential proteins by comparing the control group with HIF-1α targeted siRNA group. Real time PCR and western blot were used respectively to detect mRNA expression and protein Cell count, flow cytometry and Hoechst staining were used to evaluate cell growth and apoptosis. Matrigel invasion and wound scratch assay were performed to measure the ability of cell invasion and migration.Results: Protein expression of UCH-L3 in MDA-MB-231 cells transfected with HIF-1α-targeted siRNA was detected by Bidirectional gel electrophoresis and mass spectormetry. Constitutive expression of UCH-L3 by transfected cells with expression plasmid resulted in a decrease of HIF-1α mRNA expression accompanied a disability of migration/invasion. SiRNA targeted UCH-L3 increase protein expression of HIF-1α to some extent and facilitated clone formation and accelerated cell growth. Further constitutively lentiviral vector of UCH-L3 was transfected into cells resulting in a significant reduction of HIF-1α protein expression and a decrease of cell apoptosis. While addition of protease inhibitor MG231 in those cells arrested reduction of HIF-1α protein.Conclusion: UCH-L3 may be an important factor in regulating degradation of HIF-1α protein and regressing malignant effect of HIF-1 on tumor. Constitutive expression of UCH-L3 or application of synthetic analogues could probably be a potential means for the treatment of triple-negative breast cancer. Our previous study found that triple-negative breast cancer line MDA-MB-231 showed a higher expression of hypoxia-inducible factor 1α (HIF-1α) under nomoxic condition and a higher capability of cell growth and invasive/migratory than other breast cancer cell lines. SiRNA targed HIF-1α interrupted HIF-1α expression and suppressed the ability of cell growth and invasion/migration with a downregulation of MMP8/17/10/13 mRNA in MDA-MB-231 cell. Ubiquitin carboxyl-terminal hydrolases L3 (UCH-L3) is a kind of deubiquitinating enzyme which may hydrolyze the ubiquitinated proteins from polyubinquited compounds before degradation by proteolytic ezyme system and release ubiquitin for recycle. HIF-1α is a regulatory subunit by oxygen and degraded by ubiquitin-proteasome pathway. This study was aimed to probe the role of UCH-L3 in modulation of HIF-1α expression and its effect on malignant behavior as well as the mechanism involved. Methods: siRNA was used to interfere HIF-1α or UCH-L3 expression. Bidirectional gel electrophoresis and mass spectormetry were used to explore differential proteins by comparing the control group with HIF-1α targeted siRNA group. Real time PCR and western blot were used respectively to detect mRNA expression and protein Cell count, flow cytometry and Hoechst staining were used to evaluate cell growth and apoptosis. Matrigel invasion and wound scratch assay were performed to measure the ability of cell invasion and migration. Results: Protein expression of UCH-L3 in MDA-MB-231 cells transfected with HIF-1α-targeted siRNA was detected by Bidirectional gel electrophoresis and mass spectormetry. Constitutive expression of UCH-L3 by transfected cells with expression plasmid resulted in a decrease of HIF-1α mRNA expression accompanied a disability of migration/invasion. SiRNA targeted UCH-L3 increase protein expression of HIF-1α to some extent and facilitated clone formation and accelerated cell growth. Further constitutively lentiviral vector of UCH-L3 was transfected into cells resulting in a significant reduction of HIF-1α protein expression and a decrease of cell apoptosis. While addition of protease inhibitor MG231 in those cells arrested reduction of HIF-1α protein. Conclusion: UCH-L3 may be an important factor in regulating degradation of HIF-1α protein and regressing malignant effect of HIF-1 on tumor. Constitutive expression of UCH-L3 or application of synthetic analogues could probably be a potential means for the treatment of triple-negative breast cancer.

Expression of Hypoxia-Inducible Factor-1A Subunit is Partly Controlled by Upregulation of Ubiquitin Carboxyl-Terminal Esterase L3

Abstract P4-08-23: ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancer

MiR-23a Modulates X-linked Inhibitor of Apoptosis-Mediated Autophagy in Human Luminal Breast Cancer Cell Lines.

Over-expression of Ubiquitin Carboxy Terminal Hydrolase-L1 Induces Apoptosis in Breast Cancer Cells.

Uch-L1 Involved in Regulating the Degradation of Egfr and Promoting Malignant Properties in Drug-Resistant Breast Cancer

HMGB3 Small Interfere RNA Suppresses Mammosphere Formation of MDA-MB-231 Cells by Down-Regulating Expression of HIF1α.

MiR-183-5p inhibits lung squamous cell carcinoma survival through disrupting hypoxia adaptation mediated by HIF-1α/NDUFA4L2 axis

UBE3B promotes breast cancer progression by antagonizing HIF-2α degradation

[Effect of Silencing Hypoxia-Inducible Factor-1 Alpha by RNA Interference on Human Breast Carcinoma Cell Line].

LncRNA HIF1A-AS1 Regulates the Cellular Function of HUVECs by Globally Regulating mRNA and miRNA Expression

RHOBTB3 promotes proteasomal degradation of HIFα through facilitating hydroxylation and suppresses the Warburg effect

Overexpression of ubiquitin carboxyl terminal hydrolase-L1 enhances multidrug resistance and invasion/metastasis in breast cancer by activating the MAPK/Erk signaling pathway.

UCHL1 protects against ischemic heart injury via activating HIF-1α signal pathway

Effect of Silencing Hypoxia Inducible Factor 1α by siRNA on The Expression of Stromal Cell Derived Factor 1α in Fetal Liver Stroma Cell

UHRF1 Modulates Breast Cancer Cell Growth Via Estrogen Signaling

Urothelial Carcinoma Associated 1 is a Hypoxia-Inducible Factor-1Α-targeted Long Noncoding RNA That Enhances Hypoxic Bladder Cancer Cell Proliferation, Migration, and Invasion

The Key Network of mRNAs and miRNAs Regulated by HIF1A in Hypoxic Hepatocellular Carcinoma Cells

Hypoxia-inducible factor-1α regulates chemokine receptor type 4 to activate AKT/mTOR pathway to promote the viability and migration of diffuse large B cell lymphoma cells

Function and Mechanism Study of Hypoxia-Induced Long Non-Coding RNA 68 in Hepatocellular Carcinoma

Effect of hypoxia inducible factor-1α gene silencing on cell growth, invasion and apoptosis of BxPC-3 cells

Proteomics-based identification of two novel direct targets of hypoxia-inducible factor-1 and their potential roles in migration/invasion of cancer cells.